Roche/Chugai’s Enspryng Not Good Enough In Phase III Myasthenia Gravis Study

Three Phase III Trials Ongoing In Three Other Indications

 
• By Mandy Jackson
  
Concept of Myasthenia Gravis written on sticky notes isolated on Wooden Table.
The myasthenia gravis pharma market is growing despite some setbacks • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D